Category: News

The team at TIS Berlin (Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie) have published the results of their long-term project investigating whether an extended follow-up period improves the detection of birth defects. The results of the study are published here, and an open access PDF was also kindly provided by the study authors. Photo by Christian Bowen on Unsplash

» Read more

The American College of Obstetricians and Gynaecologists have issued a statement describing the benefits of ensuring pregnant women have adequate access to SSRI antidepressants during pregnancy. The statement (available here) was issued in response to a panel discussion held by the U.S. Food and Drug Administration (FDA) which aired on Monday 21st July.

» Read more

Researchers from Seoul National University (Republic of Korea), have published a population-based, propensity score matched cohort study investigating fetal and childhood outcomes following maternal statin use in pregnancy. More information is available here.

» Read more

A collaborative group of Brazilian researchers has published a systematic review and meta analysis of autism spectrum disorder risk following maternal antiseizure medication (ASM) use in pregnancy. The updated analysis provides pooled risk estimates for specific ASMs, demonstrating increased risks for carbamazepine, valproate and oxcarbazepine. More information can be found here.

» Read more

An update to the existing European Alliance of Associations for Rheumatology (EULAR) points to consider for use of antirheumatic drugs in reproduction, pregnancy, and lactation have been published. More information is available here. Photo by Anna Auza on Unsplash

» Read more

Researchers from Montreal, Canada, have published a systematic review of the available evidence on maternal cabergoline use in pregnancy and the risk of adverse pregnancy outcomes. More information is available here.

» Read more